Literature DB >> 285516

Cryosurgery for trichiasis.

J R Collin, D J Coster, J H Sullivan.   

Abstract

A series of 41 cases of trichiasis was treated with cryosurgery using a standard retinal cryoprobe. The failure rate was approximately 50 per cent. The results should be improved by using properly designed equipment capable of cooling the lash follicles to -20 degrees C, and ensuring that this temperature is achieved by using a tissue thermocouple. A double freeze-thaw cycle should be used and a long-acting local anaesthetic containing adrenaline. The main complication is depigmentation which is a problem only with heavily pigmented patients. Cryosurgery does have potential for the treatment of trichiasis.

Entities:  

Mesh:

Year:  1978        PMID: 285516

Source DB:  PubMed          Journal:  Trans Ophthalmol Soc U K        ISSN: 0078-5334


  7 in total

1.  Surgical management of upper lid entropion.

Authors:  E G Kemp; J R Collin
Journal:  Br J Ophthalmol       Date:  1986-08       Impact factor: 4.638

2.  Cryotherapy for trichiasis in ocular cicatricial pemphigoid.

Authors:  M J Elder; W Bernauer
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

3.  Treatment of trichiasis with a lid cryoprobe.

Authors:  R L Johnson; J R Collin
Journal:  Br J Ophthalmol       Date:  1985-04       Impact factor: 4.638

4.  Cryosurgery in treatment of trichiasis.

Authors:  S Majekodunmi
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

5.  Ruby laser for the treatment of trichiasis.

Authors:  Joan Moore; Samantha Roshani De Silva; Kate O'Hare; Roger C Humphry
Journal:  Lasers Med Sci       Date:  2008-01-05       Impact factor: 3.161

6.  Cryosurgery for trichiasis in black patients.

Authors:  D A Peart; J C Hill
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

Review 7.  Trachomatous trichiasis and its management in endemic countries.

Authors:  Saul N Rajak; J Richard O Collin; Matthew J Burton
Journal:  Surv Ophthalmol       Date:  2012-01-27       Impact factor: 6.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.